| Annual Financials | 2020 | 2021 | TTM |
Revenue  | 544 | 508 | 0 |
| Expenses | 325 | 293 | 0 |
| EBITDA | 220 | 215 | 0 |
| Operating Profit % | 40 % | 41 % | 0 % |
| Depreciation | 18 | 20 | 0 |
| Interest | 7 | 5 | 0 |
| Profit Before Tax | 194 | 185 | 0 |
| Tax | 49 | 49 | 0 |
| Net Profit | 145 | 136 | 0 |
| EPS in ₹ | 1,462.60 | 1,396.27 | 0.00 |
Blue Jet Healthcare
Blue Jet Healthcare
626.25
+13.80
(2.25%)
Market Cap
11,853.39 Cr
PE Ratio
46.80
Volume
21,20,870.00
Day High - Low
629.05 - 611.00
52W High-Low
825.00 - 325.00
Key Fundamentals
Market Cap
11,853.39 Cr
EPS
1,396.27
PE Ratio
46.80
PB Ratio
5.37
Book Value
114.11
EBITDA
214.90
Dividend Yield
0.18 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
39.96
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Blue Jet Healthcare Limited will host an analyst and investor conference call on August 3, 2026, at 5:30 PM IST to discuss its unaudited standalone financial results for the quarter ended June 30, 2026.
Akshay Bansarilal Arora and PACs confirm no encumbrance on 79.81% stake in Blue Jet Healthcare Ltd for FY26, per SEBI Regulation 31(4) annual disclosure.
Blue Jet Healthcare wins EcoVadis Silver Medal
Jul 20, 2026
Jul 20, 2026Blue Jet Healthcare awarded EcoVadis Silver Medal for sustainability, ranking in the top 15% globally with a score of 77.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,990.50 | #1 4,77,587.63 | 41.71 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 66.37 | |
8,056.00 | 2,13,861.49 | 81.06 | 11,067.00 | 13.95 | 2,568 | 13.44 | 82.30 | |
5,122.80 | 1,94,854.84 | 86.65 | 13,886.20 | 20.34 | 2,138 | 3.28 | 64.10 | |
1,473.20 | 1,19,011.77 | 35.29 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.43 | |
1,126.80 | 1,13,382.45 | 21.72 | 27,657.90 | 17.64 | 5,026 | 7.82 | 53.10 | |
2,415.00 | 1,10,421.66 | #1 20.65 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 49.50 | |
2,469.60 | 1,01,993.49 | 51.48 | 14,636.40 | 14.85 | 1,938 | 29.13 | 44.89 | |
1,816.20 | 98,048.75 | 88.28 | 6,867.80 | 22.01 | 890 | #1 123.93 | 81.68 | |
1,148.10 | 95,828.36 | 30.00 | 35,058.60 | 3.90 | 4,158 | -69.10 | 28.48 | |
1,580.20 | 90,921.21 | 26.12 | 33,384.70 | 3.21 | 3,376 | 1.99 | 57.35 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-6.62 %
Net Income Growth
-6.34 %
Cash Flow Change
5.34 %
ROE
-44.11 %
ROCE
-38.82 %
EBITDA Margin (Avg.)
4.83 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 |
| Total Assets | 375 | 536 |
| Fixed Assets | 107 | 139 |
| Current Assets | 249 | 390 |
| Capital Work in Progress | 2 | 3 |
| Investments | 34 | 37 |
| Other Assets | 233 | 358 |
| Total Equity & Liabilities | 375 | 536 |
| Current Liabilities | 133 | 163 |
| Non Current Liabilities | 39 | 33 |
| Total Equity | 203 | 340 |
| Reserve & Surplus | 182 | 320 |
| Share Capital | 1 | 10 |
Cash Flow
| Cash Flow | 2020 | 2021 |
| Net Cash Flow | 5 | 51 |
| Investing Activities | -45 | -51 |
| Operating Activities | 123 | 129 |
| Financing Activities | -73 | -28 |
Share Holding
| % Holding | Sept 2022 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
| Promoter | 100.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 79.81 % | 79.81 % | 79.81 % | 73.14 % | 73.14 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 2.01 % | 2.02 % | 2.18 % | 1.10 % | 2.29 % | 1.97 % | 1.82 % | 1.14 % | 0.88 % | 0.62 % | 0.62 % |
| DIIs | 0.00 % | 3.32 % | 2.81 % | 3.03 % | 2.14 % | 1.74 % | 2.02 % | 1.33 % | 0.94 % | 3.63 % | 4.65 % | 4.51 % | 9.12 % | 9.12 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 6.97 % | 4.73 % | 5.36 % | 5.79 % | 5.90 % | 6.30 % | 7.28 % | 8.03 % | 9.78 % | 9.91 % | 10.60 % | 10.09 % | 10.09 % |
| Others | 0.00 % | 3.71 % | 6.46 % | 3.60 % | 4.04 % | 4.17 % | 4.57 % | 3.10 % | 3.05 % | 4.95 % | 4.50 % | 4.20 % | 7.02 % | 7.02 % |
| No of Share Holders | 7 | 2,03,777 | 55,589 | 48,625 | 42,882 | 41,933 | 43,003 | 54,581 | 70,772 | 80,117 | 80,187 | 79,199 | 78,927 | 78,927 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.2 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.37 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 03 Aug 2026 |  Quarterly Result Announcement | NA | 03 Aug 2026 | 576.05 | 626.25 |
| 18 Sept 2024 |  Dividend | ₹ 1.00 /share | 17 Sept 2024 | 375.60 | 526.85 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 517.20 | 537.80 |
| 29 Oct 2024 | Quarterly Result Announcement | NA | 29 Oct 2024 | 473.65 | 480.30 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 581.00 | 572.95 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 723.30 | 769.30 |
| 22 Jul 2025 | Quarterly Result Announcement | NA | 22 Jul 2025 | 955.20 | 1,006.80 |
| 19 Sept 2025 | Dividend | ₹ 1.20 /share | 19 Sept 2025 | 769.30 | 683.55 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 770.70 | 664.85 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 638.55 | 674.75 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 406.70 | 441.60 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 421.05 | 441.05 |
| 17 Jun 2026 |  Extraordinary General Meeting | NA | 17 Jun 2026 | 482.50 | 510.40 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoBoard Meeting Intimation for Approval Of Unaudited Standalone Financial Results Of The Company For The First Quarter Ended June 30 2026 Along With Limited Review Report Thereon3 days ago
3 days agoPress Release -Blue Jet Healthcare Limited Has Been Awarded With Silver Medal By EcovadisJul 20, 2026
Jul 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Jul 14, 2026Announcement under Regulation 30 (LODR)-Qualified Institutional PlacementJul 09, 2026
Jul 09, 2026Announcement under Regulation 30 (LODR)-Qualified Institutional PlacementJul 09, 2026
Jul 09, 2026Announcement under Regulation 30 (LODR)-Qualified Institutional PlacementJul 06, 2026
Jul 06, 2026Audited Standalone Financial Statement For The Financial Year Ended March 31 2026Jul 06, 2026
Jul 06, 2026Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJul 06, 2026
Jul 06, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 18, 2026
Jun 18, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMJun 17, 2026
Jun 17, 2026Clarification On Volume MovementJun 12, 2026
Jun 12, 2026Clarification sought from Blue Jet Healthcare LtdJun 12, 2026
Jun 12, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2026
May 29, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Notice Of Extra-Ordinary General Meeting Of Blue Jet Healthcare LimitedMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Corporate Action-Board approves DividendMay 25, 2026
May 25, 2026Financial Results For March 31 2026May 25, 2026
May 25, 2026Board Meeting Outcome for Outcome Of Board MeetingMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
May 19, 2026Board Meeting Intimation for As Per Attached PdfMay 19, 2026
May 19, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 28, 2026
Feb 28, 2026Company UpdateFeb 19, 2026
Feb 19, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Feb 13, 2026Outcome Of Board MeetingFeb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Board MeetingFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Feb 06, 2026Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 06, 2026
Feb 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingDec 17, 2025
Dec 17, 2025Update On Implementation Of 1.0 Of SAP S/4HANA By Blue Jet Healthcare LimitedDec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 04, 2025
Nov 04, 2025Unaudited Financial Result For The Quarter And Half Year Ended September 30 2025Nov 04, 2025
Nov 04, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 65.37
ATR(14)
Less Volatile 22.76
STOCH(9,6)
Neutral 42.10
STOCH RSI(14)
Neutral 43.61
MACD(12,26)
Bearish -2.47
ADX(14)
Strong Trend 46.09
UO(9)
Bearish 47.92
ROC(12)
Uptrend And Accelerating 1.15
WillR(14)
Neutral -20.21
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
